| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185558 | Gynecologic Oncology | 2013 | 4 Pages |
Abstract
Pre-treatment in vitro cisplatin chemoresponse testing of cervix cancer biopsies was technically feasible and prognostic of RFS in patients treated with weekly cisplatin chemoRT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Perry W. Grigsby, Israel Zighelboim, Matthew A. Powell, David G. Mutch, Julie K. Schwarz,